ISO 14971 is the international standard that defines how to identify, evaluate and control risk across the entire lifecycle of a medical device. We help you build a risk management process that is practical, defensible and ready for audit.
ISO 14971 sets out a systematic process for risk management throughout the lifecycle of a medical device. It is referenced in virtually every regulatory framework worldwide and forms the foundation of a defensible safety argument.
Risk management under ISO 14971 is not a one-off activity. It runs from concept through development, into production, and continues with post-market surveillance, feeding back into your design and processes.
Globally recognisedRequired or expected by EU MDR, FDA, TGA, Medsafe, MHRA, NMPA, PMDA. The shared language of safety.
Latest version: ISO 14971:2019Aligned with EN ISO 14971:2019/A11:2021 for the EU and supported by ISO/TR 24971 guidance.
Lifecycle obligationRisk management activities are continuous. Findings from production and post-market surveillance feed back into the file.
Key Requirements
What ISO 14971 covers
Risk management plan and risk management file
Risk analysis: identifying hazards and hazardous situations
Risk evaluation against defined acceptability criteria
Risk control: design, protective measures, and information
Evaluation of overall residual risk
Production and post-production information loop
Benefit-risk analysis for residual risks
Risk management review by top management
Integration with the QMS and design controls
Reporting under post-market surveillance and vigilance
How We Help
ISO 14971 services from Elevate MedTech
Whether you are setting up your risk management process from scratch or updating a legacy file, we work with you end to end.
Risk Management Plan
We draft a plan that fits the size and complexity of your device, your team, and your target markets.
Hazard Analysis Workshops
Facilitated sessions with your team to systematically identify hazards, hazardous situations and harms.
Risk File Build & Review
We build or review your risk management file, including FMEA, fault tree, or hazard tables as appropriate.
Post-Market Risk Loop
We integrate PMS, PMCF and complaint data back into your risk file, closing the lifecycle loop.
Benefit-Risk Analysis
A defensible benefit-risk justification for residual risks, aligned with MDR, FDA and ISO 14971:2019 expectations.
Training & Coaching
In-house training or 1:1 coaching for your R&D, RA and QA teams. Practical, example-driven, RBP certified.
FAQ
Frequently asked questions about ISO 14971
ISO 14971 itself is not law, but conformance to it is the recognised way to meet risk management requirements in virtually every market. EU MDR, FDA, TGA, Medsafe, MHRA and most Asian regulators expect a process aligned with ISO 14971.
FMEA is a tool. ISO 14971 is a framework. You can use FMEA, fault tree analysis or hazard tables inside an ISO 14971 process. The standard is method-neutral, what matters is that risks are systematically identified, evaluated and controlled.
ISO 13485 requires you to have a risk management process. ISO 14971 tells you what that process should look like for medical devices. The two work hand in hand: your QMS owns the process, your risk file owns the evidence.
The A11 amendment adapts ISO 14971 for use in the EU under MDR and IVDR. It clarifies how the standard supports the General Safety and Performance Requirements. If you sell in the EU, this is the version you align to.
Related Standards
ISO 14971 works alongside
These standards are tightly woven into a full risk management approach.